HNN3.0
Register
Register
Register

Project cooperationUpdated on 12 January 2026

Climate-Neutral Point-of-Care 3D Printed Regenerative Bone Implants for Resilient Healthcare Systems

BioProducts R&D Manager | Regulatory Compliance Officer at COLFEED4Print

Madrid, Spain

About

Project Concept

The project aims to design and validate 3D printed, patient-specific bone-regenerative implants manufactured directly within hospital and clinic-based 3D printing units. By moving production to the point of care, the project addresses several key environmental and healthcare challenges:

  • Reduced carbon footprint by eliminating centralized manufacturing and logistics

  • Use of carbon-neutral biomaterials

  • Fewer secondary surgeries through improved implant integration and regeneration

  • Faster clinical response and improved healthcare system resilience

  • Democratization of access to regenerative implant technologies, including dentistry

Applications may include orthopedics, maxillofacial surgery, trauma and dental regeneration, with a strong focus on real-world clinical workflows.

COLFEED is a biomaterial producer for FDM 3D printing, with patented, functionalized and easy-to-print feedstocks already validated in hospital-based point-of-care manufacturing environments. COLFEED contributes:

  • Carbon-neutral, regenerative biomaterials

  • Printability-focused material design for clinical settings

  • Experience integrating materials into existing hospital 3D printing units

  • Know-how in scalability, sustainability and clinical translation

Partners may contribute to clinical validation, manufacturing systems, sustainability assessment, regulatory pathways or healthcare deployment models.

Topic

  • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems

Similar opportunities

  • Project cooperation

    Advanced 3D-Printed Biomaterial and Bioink Platforms for Disease-Specific cellular models

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Lucia Gallego

    BioProducts R&D Manager | Regulatory Compliance Officer at COLFEED4Print

    Madrid, Spain

  • Project cooperation

    Biomaterials and Additive Manufacturing

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Bartolomeo Coppola

    Associate Professor at Politecnico di Torino

    Torino, Italy

  • Project cooperation

    3D-Bioprinted Scaffolds for Drug Delivery & Tissue Regeneration Partnership

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Sema Bayraktar

    Research and Development Scientist at BlooCell

    Istanbul, Türkiye